{"mainPropery":{"diseaseId":12892,"diseaseName":"Combined oxidative phosphorylation deficiency 16","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/12892/combined-oxidative-phosphorylation-deficiency-16","synonyms":["Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency","Combined oxidative phosphorylation defect type 16","COXPD16"],"synonyms-with-source":[{"name":"Infantile hypertrophic cardiomyopathy due to MRPL44 deficiency","source":"Orphanet"},{"name":"Combined oxidative phosphorylation defect type 16","source":"Orphanet"},{"name":"COXPD16","source":"Orphanet"}],"identifiers":[{"identifierType":"OMIM","identifierId":"615395"},{"identifierType":"ORPHANET","identifierId":"352563"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":4,"diseaseTypeName":"Heart Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"}],"organizations":[],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/615395' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=352563' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:615395' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":9933,"questionText":"What is combined oxidative phosphorylation deficiency 16?","answerText":"<strong>Combined oxidative phosphorylation deficiency</strong>&nbsp;<strong>16</strong>, also know as infantile hypertrophic cardiomyopathy, is characterized by decreased levels of <a href=\"http://ghr.nlm.nih.gov/geneFamily/mitochondrialrespiratorychaincomplex\" target=\"_blank\">mitochondrial complexes</a>.  The symptoms and signs described include an enlarged heart muscle (<a href=\"http://www.heart.org/HEARTORG/Conditions/More/Cardiomyopathy/Hypertrophic-Cardiomyopathy_UCM_444317_Article.jsp#.Vo9JbrYrKM8\" target=\"_blank\">hypertrophic cardiomyopathy</a>) and fatty liver (hepatic steatosis), as well as eye problems, headache, paralysis of one side of the body, <a href=\"http://www.umdf.org/site/c.8qKOJ0MvF7LUG/b.8637485/k.8A22/Leighs_Disease.htm\" target=\"_blank\">Leigh-like lesions</a> on brain magnetic resonance imaging (MRI), kidney insufficiency and neurological disease.[10368] It is caused by <a href=\"http://www.genome.gov/Glossary/index.cfm?id=134\" target=\"_blank\">mutations</a>  in the   <a href=\"http://ghr.nlm.nih.gov/gene/MRPL44\" target=\"_blank\"><em>MRPL44</em> gene</a>, which results in mitochondrial dysfunction.  The cases described seem to be inherited in an <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/002052.htm\" target=\"_blank\">autosomal recessive</a>  pattern. Treatment is supportive.[10368][10369]","dateModified":"2016-01-08T00:03:00"},"basicQuestions":[],"references":[],"relatedDiseases":[{"relatedDiseaseId":12893,"relatedDiseaseName":"Combined oxidative phosphorylation deficiency","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":4319,"phenoTypeName":"Elevated hepatic transaminase","percentRanges":"-"},{"phenoTypeId":8970,"phenoTypeName":"Hypertrophic cardiomyopathy","percentRanges":"-"},{"phenoTypeId":13834,"phenoTypeName":"Increased serum lactate","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":5705,"phenoTypeName":"Microvesicular hepatic steatosis","percentRanges":"-"},{"phenoTypeId":7381,"phenoTypeName":"Variable expressivity","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Combined_oxidative_phosphorylation_deficiency_16"}